Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  SANOFI    SAN   FR0000120578


SummaryQuotesChart AnalysisNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Sanofi: Tests Show Zaltrap Improves Colorectal Cancer Survival Rate

10/08/2012 | 01:44am US/Eastern

French drug company Sanofi SA (>> SANOFI) Monday said results from the pivotal Phase III Velour study evaluating Zaltrap showed improvement in overall survival rate to colorectal cancer.


- Sanofi said the Journal of Clinical Oncology published the results of the study evaluating Zaltrap effects.

- In the Velour trial evaluating metastatic colorectal cancer patients previously treated with an oxaliplatin-containing regimen, Zaltrap in combination with the Folfiri chemotherapy regimen (5-fluorouracil, leucovorin, irinotecan) showed a statistically significant improvement in overall survival, progression-free survival, and the overall tumor response rate versus placebo plus Folfiri.

- The Velour data supported the regulatory approval of Zaltrap by the U.S. Food and Drug Administration (FDA) on August 3, 2012 after a Priority Review.

- Zaltrap is under review at the European Medicines Agency and other regulatory agencies worldwide, Sanofi says.

-Write to Inti Landauro at

Subscribe to WSJ:

Stocks mentioned in the article : SANOFI
React to this article
Latest news on SANOFI
15h ago BAYER : to divest equine assets to Merial; Divestiture includes Legend /Hyonate ..
16h ago SANOFI : Merial acquires two major equine health products from Bayer - Acquisiti..
16h ago SANOFI : Bayer to divest equine assets to Merial
1d ago SANOFI : Studies from Sanofi Yield New Information about Solid Cancer (Phase I d..
1d ago SANOFI : Pasteur Announces FDA Approval of Fluzone® Intradermal Quadrivalent Inf..
1d ago SANOFI : United Way of Monroe County Receives Largest Sanofi Pasteur Contributio..
1d ago SANOFI : BSR Report 2013-2014 Case Study | Sanofi: Using Materiality to Build a ..
1d ago SANOFI : United Way lands on Sanofi's Park Place
1d agoDJBayer Plans to Sell Equine-Health Products to Sanofi Unit
1d ago SANOFI : Merial acquires two major equine health products from Bayer
Duration : Period :
SANOFI Technical Analysis Chart | SAN | FR0000120578 | 4-Traders
Income Statement Evolution
More Financials
Dynamic quotes